Literature DB >> 30357544

Neuroendocrine neoplasms - think about it and choose the most appropriate diagnostic and therapeutic steps.

Christian A Koch1,2,3,4, S Petersenn5,6.   

Abstract

Entities:  

Mesh：

Year:  2018        PMID： 30357544     DOI： 10.1007/s11154-018-9472-1

Source DB:  PubMed          Journal:  Rev Endocr Metab Disord        ISSN： 1389-9155            Impact factor:   6.514


× No keyword cloud information.
  23 in total

1.  Ectopic calcitonin secretion in a woman with large cell neuroendocrine lung carcinoma.

Authors:  Goran Cvijovic; Dragan Micic; Aleksandra Kendereski; Svetlana Zoric; Mirjana Sumarac-Dumanovic; Svetislav Tatic; Aleksandar Trivic; Danica Pejkovic-Stamenkovic; Danka Jeremic
Journal:  Hormones (Athens)       Date:  2013 Oct-Dec       Impact factor: 2.885

Review 2.  Somatostatin receptor expression in non-classical locations - clinical relevance?

Authors:  Eldrin Bhanat; Christian A Koch; Rinkuben Parmar; Vishnu Garla; Vani Vijayakumar
Journal:  Rev Endocr Metab Disord       Date:  2018-06       Impact factor: 6.514

3.  The first prospective trial for von Hippel-Lindau disease: pazopanib.

Authors:  Rachel H Giles; Sven Gläsker
Journal:  Lancet Oncol       Date:  2018-09-17       Impact factor: 41.316

4.  Metastatic neuroendocrine tumor of the esophagus with features of medullary thyroid carcinoma.

Authors:  Raymond M Fertig; Adam Alperstein; Carlos Diaz; Kyle D Klingbeil; Sameera S Vangara; Ryosuke Misawa; Jennifer Reed; Sudeep Gaudi
Journal:  Intractable Rare Dis Res       Date:  2017-08

Review 5.  Calcitonin-Producing Neuroendocrine Neoplasms of the Pancreas: Clinicopathological Study of 25 Cases and Review of the Literature.

Authors:  Silvia Uccella; Annika Blank; Roberta Maragliano; Fausto Sessa; Aurel Perren; Stefano La Rosa
Journal:  Endocr Pathol       Date:  2017-12       Impact factor: 3.943

6.  Long-Term Natural Course of Small Nonfunctional Pancreatic Neuroendocrine Tumors in MEN1-Results From the Dutch MEN1 Study Group.

Authors:  Carolina R C Pieterman; Joanne M de Laat; Jos W R Twisk; Rachel S van Leeuwaarde; Wouter W de Herder; Koen M A Dreijerink; Ad R M M Hermus; Olaf M Dekkers; Anouk N A van der Horst-Schrivers; Madeleine L Drent; Peter H Bisschop; Bastiaan Havekes; Inne H M Borel Rinkes; Menno R Vriens; Gerlof D Valk
Journal:  J Clin Endocrinol Metab       Date:  2017-10-01       Impact factor: 5.958

7.  Efficacy of Peptide Receptor Radionuclide Therapy for Functional Metastatic Paraganglioma and Pheochromocytoma.

Authors:  Grace Kong; Simona Grozinsky-Glasberg; Michael S Hofman; Jason Callahan; Amichay Meirovitz; Ofra Maimon; David A Pattison; David J Gross; Rodney J Hicks
Journal:  J Clin Endocrinol Metab       Date:  2017-09-01       Impact factor: 5.958

8.  Development of effective prophylaxis against intraoperative carcinoid crisis.

Authors:  Eugene A Woltering; Anne E Wright; Melissa A Stevens; Yi-Zarn Wang; John P Boudreaux; Gregg Mamikunian; James M Riopelle; Alan D Kaye
Journal:  J Clin Anesth       Date:  2016-04-20       Impact factor: 9.452

9.  Pheochromocytoma associated with hypercalcemia and ectopic secretion of calcitonin.

Authors:  H Heath; A J Edis
Journal:  Ann Intern Med       Date:  1979-08       Impact factor: 25.391

10.  Detection of Polyethylene Glycol Thyrotropin (TSH) Precipitable Percentage (Macro-TSH) in Patients with a History of Thyroid Cancer.

Authors:  Massimo Giusti; Lucia Conte; Anna Maria Repetto; Stefano Gay; Paola Marroni; Miranda Mittica; Michele Mussap
Journal:  Endocrinol Metab (Seoul)       Date:  2017-12
View more
  3 in total

Review 1.  Clinical applications of (epi)genetics in gastroenteropancreatic neuroendocrine neoplasms: Moving towards liquid biopsies.

Authors:  Gitta Boons; Timon Vandamme; Marc Peeters; Guy Van Camp; Ken Op de Beeck
Journal:  Rev Endocr Metab Disord       Date:  2019-09       Impact factor: 6.514

Review 2.  Peptide Receptor Radionuclide Therapy in Thyroid Cancer.

Authors:  Sriram Gubbi; Christian A Koch; Joanna Klubo-Gwiezdzinska
Journal:  Front Endocrinol (Lausanne)       Date:  2022-05-30       Impact factor: 6.055

3.  Frequency and Causes of False-Positive Elevated Plasma Concentrations of Fasting Gut Hormones in a Specialist Neuroendocrine Tumor Center.

Authors:  Olivia L Butler; Monica M Mekhael; Arslan Ahmed; Daniel J Cuthbertson; D Mark Pritchard
Journal:  Front Endocrinol (Lausanne)       Date:  2020-12-16       Impact factor: 5.555
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.